SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-075270
Filing Date
2011-03-23
Accepted
2011-03-23 16:42:01
Documents
5
Period of Report
2011-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 23251
2 INDENTURE, DATED AS OF MARCH 17, 2011 BY AND AMONG THE COMPANY dex41.htm EX-4.1 663338
3 FORM OF 12% SENIOR SECURED NOTE DUE 2015 ISSUED BY THE COMPANY dex42.htm EX-4.2 56795
4 FORM OF PURCHASE AGREEMENT dex101.htm EX-10.1 147981
5 PLEDGE AND SECURITY AGREEMENT dex102.htm EX-10.2 226795
  Complete submission text file 0001193125-11-075270.txt   1119392
Mailing Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044
Business Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-09601 | Film No.: 11706893
SIC: 2834 Pharmaceutical Preparations